实用医学杂志 ›› 2020, Vol. 36 ›› Issue (22): 3149-3152.doi: 10.3969/j.issn.1006⁃5725.2020.22.024

• 综述 • 上一篇    下一篇

LncRNA及miRNA对NLRP3炎症小体信号的调控机制及其在相关疾病中的意义

陆佳伟,刘效谷,张文波   

  1. 江苏大学附属人民医院普外科(江苏镇江212002)
  • 出版日期:2020-11-25 发布日期:2020-12-14
  • 通讯作者: 张文波E⁃mail:wb.zhan@hotmail.com
  • 基金资助:
    国家自然科学基金青年基金面上项目(编号:81500193,81802409);中国博士后科学基金(编号:2015M571703);江苏省自然科学基金面上项目(编号:BK20161353);江苏省青年医学重点人才项目(编号:QNRC2016454);镇江市重点研发计划社会发展面上项目(编号:SH2018057,SH2018072)

The regulatory mechanism of lncRNA and miRNA on NLRP3 inflammasome signal and non⁃coding RNA′s role in associated diseases

LU Jiawei,LIU Xiaogu,ZHANG Wenbo   

  1. Department of General Surgery,Affiliated People′s Hospital of Jiangsu University,Zhenjiang 212002,China
  • Online:2020-11-25 Published:2020-12-14
  • Contact: ZHANG Wenbo E⁃mail:wb.zhan@hotmail.com
  • Supported by:


摘要:

NLRP3 炎症小体是先天免疫系统的重要组成部分,能够介导caspase⁃1 激活,促进前炎症因子白介素(interleukin,IL)⁃1β/IL⁃8的释放。NLRP3炎症小体的异常激活已被证明与多种疾病有关,包括帕金森、动脉粥样硬化、急性肺损伤等疾病。非编码RNA(non⁃coding RNA,ncRNA)如微小RNA(microR⁃NA,miRNA)和长链非编码RNA(long non⁃coding RNA,lncRNA)是指不能编码蛋白质的RNA分子,能够在转录或转录后水平调控NLRP3的表达,并在NLRP3炎症小体异常激活的相关疾病中发挥重要作用。本文就相关领域的最新进展展开综述,以期为进一步治疗NLRP3炎性小体相关疾病提供新的思路。

关键词: 非编码RNA, lncRNA, miRNA, NLRP3炎症小体

Abstract:

The NLRP3 inflammasome is an immportant component of the innate immune system thatmediates caspase⁃1 activation and the secretion of pro⁃inflammatory cytokines IL⁃1β/IL⁃8. However,the aberrantactivation of the NLRP3 inflammasome has been linked with several diseases,such as parkinson disease,athero⁃sclerosis,acute lung injury and etc. Non⁃coding RNAs,such as miRNA and lncRNA,refer to RNAs which cannot code for proteins but can regulate the expression of NLRP3 at transcription or post⁃transcription level and partic⁃ipate in the progress of diverse NLRP3⁃related diseases. In this review,the latest developments in this area will beelucidated to provide new insights for further treatment of NLRP3⁃related diseases.

Key words: non?coding RNA, lncRNA, miRNA, NLRP3 inflammasome